Entacapone in restless legs syndrome.
Identifieur interne : 006199 ( Main/Merge ); précédent : 006198; suivant : 006200Entacapone in restless legs syndrome.
Auteurs : Ashfaq A. Sharif [États-Unis]Source :
- Movement disorders : official journal of the Movement Disorder Society [ 0885-3185 ] ; 2002.
English descriptors
- KwdEn :
- Antiparkinson Agents (administration & dosage), Carbidopa (administration & dosage), Catechols (administration & dosage), Delayed-Action Preparations, Drug Combinations, Drug Therapy, Combination, Female, Humans, Levodopa (administration & dosage), Middle Aged, Neurologic Examination (drug effects), Nitriles, Restless Legs Syndrome (drug therapy).
- MESH :
- chemical , administration & dosage : Antiparkinson Agents, Carbidopa, Catechols, Levodopa.
- chemical : Delayed-Action Preparations, Drug Combinations, Nitriles.
- drug effects : Neurologic Examination.
- drug therapy : Restless Legs Syndrome.
- Drug Therapy, Combination, Female, Humans, Middle Aged.
Abstract
Entacapone increased the duration of action of carbidopa-levodopa and resulted in longer periods of symptomatic relief in a patient with restless legs syndrome. The only side effect was nausea.
PubMed: 11921139
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 003B06
- to stream PubMed, to step Curation: 003B06
- to stream PubMed, to step Checkpoint: 003B01
- to stream Ncbi, to step Merge: 000745
- to stream Ncbi, to step Curation: 000745
- to stream Ncbi, to step Checkpoint: 000745
Links to Exploration step
pubmed:11921139Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Entacapone in restless legs syndrome.</title><author><name sortKey="Sharif, Ashfaq A" sort="Sharif, Ashfaq A" uniqKey="Sharif A" first="Ashfaq A" last="Sharif">Ashfaq A. Sharif</name><affiliation wicri:level="2"><nlm:affiliation>Neurologic Consultants, P.A., Maplewood, Minnesota, USA. nawazone@yahoo.com</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Neurologic Consultants, P.A., Maplewood, Minnesota</wicri:regionArea><placeName><region type="state">Minnesota</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2002">2002</date><idno type="RBID">pubmed:11921139</idno><idno type="pmid">11921139</idno><idno type="wicri:Area/PubMed/Corpus">003B06</idno><idno type="wicri:Area/PubMed/Curation">003B06</idno><idno type="wicri:Area/PubMed/Checkpoint">003B01</idno><idno type="wicri:Area/Ncbi/Merge">000745</idno><idno type="wicri:Area/Ncbi/Curation">000745</idno><idno type="wicri:Area/Ncbi/Checkpoint">000745</idno><idno type="wicri:doubleKey">0885-3185:2002:Sharif A:entacapone:in:restless</idno><idno type="wicri:Area/Main/Merge">006199</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Entacapone in restless legs syndrome.</title><author><name sortKey="Sharif, Ashfaq A" sort="Sharif, Ashfaq A" uniqKey="Sharif A" first="Ashfaq A" last="Sharif">Ashfaq A. Sharif</name><affiliation wicri:level="2"><nlm:affiliation>Neurologic Consultants, P.A., Maplewood, Minnesota, USA. nawazone@yahoo.com</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Neurologic Consultants, P.A., Maplewood, Minnesota</wicri:regionArea><placeName><region type="state">Minnesota</region></placeName></affiliation></author></analytic><series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title><idno type="ISSN">0885-3185</idno><imprint><date when="2002" type="published">2002</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiparkinson Agents (administration & dosage)</term><term>Carbidopa (administration & dosage)</term><term>Catechols (administration & dosage)</term><term>Delayed-Action Preparations</term><term>Drug Combinations</term><term>Drug Therapy, Combination</term><term>Female</term><term>Humans</term><term>Levodopa (administration & dosage)</term><term>Middle Aged</term><term>Neurologic Examination (drug effects)</term><term>Nitriles</term><term>Restless Legs Syndrome (drug therapy)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Antiparkinson Agents</term><term>Carbidopa</term><term>Catechols</term><term>Levodopa</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Delayed-Action Preparations</term><term>Drug Combinations</term><term>Nitriles</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Neurologic Examination</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Restless Legs Syndrome</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Drug Therapy, Combination</term><term>Female</term><term>Humans</term><term>Middle Aged</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Entacapone increased the duration of action of carbidopa-levodopa and resulted in longer periods of symptomatic relief in a patient with restless legs syndrome. The only side effect was nausea.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006199 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 006199 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Merge
|type= RBID
|clé= pubmed:11921139
|texte= Entacapone in restless legs syndrome.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/RBID.i -Sk "pubmed:11921139" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd \
| NlmPubMed2Wicri -a MovDisordV3
| This area was generated with Dilib version V0.6.23. |  |